Baltimore-Washington Financial Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-41,736
Closed -$3.3M 75
2016
Q3
$3.3M Sell
41,736
-3,349
-7% -$272K 0.94% 51
2016
Q2
$3.76M Buy
45,085
+2,111
+5% +$187K 1.12% 45
2016
Q1
$3.95M Buy
42,974
+2,798
+7% +$252K 1.2% 40
2015
Q4
$4.07M Buy
40,176
+1,572
+4% +$164K 1.27% 35
2015
Q3
$3.79M Sell
38,604
-94
-0.2% -$10.4K 1.2% 38
2015
Q2
$4.53M Buy
38,698
+415
+1% +$45.3K 1.35% 36
2015
Q1
$3.76M Buy
38,283
+1,610
+4% +$163K 1.09% 40
2014
Q4
$3.46M Buy
36,673
+1,080
+3% +$112K 1.03% 42
2014
Q3
$3.79M Buy
35,593
+768
+2% +$75.2K 1.21% 37
2014
Q2
$2.89M Buy
34,825
+3,770
+12% +$293K 0.9% 48
2014
Q1
$2.2M Buy
31,055
+3,345
+12% +$262K 0.75% 58
2013
Q4
$2.08M Buy
27,710
+5,785
+26% +$403K 0.7% 64
2013
Q3
$1.38M Buy
+21,925
New +$1.31M 0.55% 65

Other funds holding GILD

Baltimore-Washington Financial Advisors's GILD Position: Q4 2016 in Review

Baltimore-Washington Financial Advisors sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 41,736 shares — an estimated $3.3M sold.

Baltimore-Washington Financial Advisors first reported a position in GILD in Q3 2013 and held it in 13 quarters. The position peaked at $4.53M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Baltimore-Washington Financial Advisors reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 41,736 Gilead Sciences shares in Q4 2016, an estimated $3.3M.
  • Baltimore-Washington Financial Advisors first reported a position in Gilead Sciences in Q3 2013 and held it in 13 quarters.
  • Baltimore-Washington Financial Advisors's Gilead Sciences position peaked at $4.53M in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2016, filed 12 Jan 2017.